Home › Funds › Knoll Capital Management, LLC › PHAR
Knoll Capital Management, LLC position in PHAR
PHARMING GROUP NV · Health Care
Knoll Capital Management, LLC reported holding 4,091 shares of PHAR (PHARMING GROUP NV) in its Q2 2026 13F filing — a position valued at US$57K, representing 0.03% of its reported portfolio and ranking #36 among its reported holdings. Knoll Capital Management, LLC has disclosed PHAR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Knoll Capital Management, LLC's PHAR position evolved
Knoll Capital Management, LLC first disclosed a stake in PHAR in Q1 2026 at 4,057 shares (US$68K). Across 2 filings, Knoll Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,091 shares valued at US$57K — an increase of 34 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 4.06K | $67.51K | New |
| Q2 2026 | 4.09K | $56.82K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PHAR and 13F data
PHAR (PHARMING GROUP NV) is a Health Care company. 15 other funds we track also report a position in PHAR — the largest reported positions include Silverberg Bernstein Capital Management LLC (US$358K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PHAR
- Silverberg Bernstein Capital Management LLC 35.79K sh · $357.51K · Q3 2026
More on Knoll Capital Management, LLC
FAQ
How long has Knoll Capital Management, LLC held PHAR?
Knoll Capital Management, LLC has disclosed PHAR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Knoll Capital Management, LLC's current position in PHAR?
As of Q2 2026, Knoll Capital Management, LLC holds 4.09K shares of PHAR (PHARMING GROUP NV), valued at $56.82K, representing 0.03% of its reported portfolio and ranking #36.
Has Knoll Capital Management, LLC been buying or selling PHAR?
In the latest 13F filing (Q2 2026), Knoll Capital Management, LLC increased its position in PHAR.
Which other funds hold PHAR?
Other major institutional holders of PHAR include Silverberg Bernstein Capital Management LLC, among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.